Table 2.
Comparison between the 2 groups of the proportion of patients in the categories with platelet count of 50,000/μl as the minimum during the study and 1 month after stopping treatment
| Montha | Platelet count categoryb | Group |
P valuec | |
|---|---|---|---|---|
| Prophylaxis n (%) | Nonprophylaxis n (%) | |||
| 1 | 1 | 2 (1.0) | 2 (2.2) | 0.613 |
| 2 | 72 (42.8) | 19 (20.6) | ||
| 3 | 95 (56.2) | 71 (77.2) | ||
| 2 | 1 | 2 (1.2) | 2 (2.2) | 0.613 |
| 2 | 69 (40.8) | 16 (17.4) | ||
| 3 | 98 (58.0) | 74 (80.4) | ||
| 3 | 1 | 4 (2.4) | 2 (2.2) | 1.000 |
| 2 | 68 (40.2) | 15 (16.3) | ||
| 3 | 97 (57.4) | 74 (81.5) | ||
| 4 | 1 | 3 (1.8) | 2 (2.2) | 1.000 |
| 2 | 67 (40.2) | 14 (16.3) | ||
| 3 | 97 (58.0) | 72 (81.5) | ||
| 5 | 1 | 3 (1.8) | 1 (1.1) | 1.000 |
| 2 | 54 (33.1) | 19 (21.7) | ||
| 3 | 107 (65.1) | 66 (77.2) | ||
| 6d | 1 | 4 (2.4) | 1 (1.1) | 0.660 |
| 2 | 49 (30.2) | 15 (17.4) | ||
| 3 | 110 (67.5) | 69 (81.5) | ||
There was no statistically significant difference in platelet counts at baseline between the 2 groups.
a
Month after start of treatment.
b
Platelet count categories (per μl): 1: ≤ 50,000; 2: 51,000−150,000; 3: ≥150,000.
c
Fisher exact test.
d
One month after stopping treatment.